Abstract
Induced pluripotent stem cell-derived cerebral organoids are an innovative human model of the brain that could improve translation of gene therapy to the clinic. Depla et al. demonstrate the application of cerebral organoids as a preclinical model for AAV capsid selection and testing efficacy of therapeutic transgenes.
Original language | English |
---|---|
Pages (from-to) | 167-175 |
Number of pages | 9 |
Journal | Molecular Therapy - Methods and Clinical Development |
Volume | 18 |
Early online date | 1 Jun 2020 |
DOIs | |
Publication status | Published - 11 Sept 2020 |
Keywords
- AAV
- CNS
- Cerebral organoids
- SCA3
- Transduction
- adeno-associated virus
- central nervous system
- gene therapy
- iPSC
- induced pluripotent stem cells
- miRNA
- micro RNA
- organoids
- spinocerebellar ataxia 3